1. Ganoderma Reishi Spore oil : Effects of Triterpene 42%
  2. Ganoderma lucidum: Potent Medicinal Mushroom with Numerous Health Benefits
  3.  Anti-inflammatoryhttp://www.ncbi.nlm.nih.gov/pubmed/17311233
  4. Ganoderma lucidum for As Treatment: https://journals.sagepub.com/doi/10.1177/1534735414568721
  5. The Mushroom Ganoderma Lucidum Suppresses Breast-To-Lung : https://pubmed.ncbi.nlm.nih.gov/24718855/
  6. Radio-protection: http://www.ncbi.nlm.nih.gov/pubmed/21944902
  7. Ganoderma lucidum (Reishi) in treatment: https://journals.sagepub.com/doi/pdf/10.1177/1534735403259066
  8. Sleep and heart regulation: http://www.ncbi.nlm.nih.gov/pubmed/22207209


      1. Bojana B, Marin B, Zhang JS, et al. Ganoderma Lucidum and its pharmaceuticallyactive compounds. Biotech Ann Rev. 2007;13:265–301. [PubMed2. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol. 1992;37:101–134. [PubMed

      3. Lin ZB, Wang PY. The pharmacological study of Ganoderma spores and their active compounds. J Peking Univ (Health Sciences) 2006;38(5):541–547. [PubMed] []

      4. Zhang W, Zeng YS. Progress on the spores of Ganoderma Lucidum. J Chin Intergr Med. 2004;2(6):463–465. []
      5. Chen RY, Yu DQ. Progress on triterpenoids of Ganoderma Lucidum. Acta Pharm Sin. 1990;25(12):940–953. [PubMed
      6. Luo J, Lin ZB. Advances of pharmacological effects of triterpenes from Ganoderma Lucidum. Acta Pharm Sin. 2002;37(7):574–578. [PubMed
      7. Qiao Y, Yang YK, Dong XC, et al. 13C NMR chemical shifts of Ganoderma triterpenoids: a meta-analysis. Chin J Mag Res. 2005;22(4):437–456. 
      8. Cheng CR, Yue QX, Wu ZY, et al. Cytotoxic triterpenoids from Ganoderma Lucidum. Phytochemistry. 2010;71:1579–1585. [PubMed
      9. Hou CY, Sun YT, Yan L, et al. Studies on the chemical constituents of the spores from Ganoderma Lucidum. Acta Bot Sin. 1988;30(1):66–70. 
      10. Chen RY, Yu DQ. Studies on the triterpenoid constituents of the spores of Ganoderma Lucidum Karst. J Chine Pharm Sci. 1993;2(2):91–96. 
      11. Chen RY, Yu DQ. Application of 2D NMR techniques in the structure determination of ganosporelactone A and B. Acta Pharm Sin. 1991;26(6):430–436. [PubMed]
      12. Min BS, Nakamura N, Miyashiro H, et al. Triterpenes from the spores of Ganoderma Lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull. 1998;46(10):1607–1612. [PubMed
      13. Min BS, Gao JJ, Nakamura N, et al. Triterpenes from the spores of Ganoderma Lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull. 1998;48(7):1026–1033. [PubMed
      14. Min BS, Gao JJ, Hattori M, et al. Anticomplement activity of triterpenoids from the spores of Ganoderma Lucidum. Planta Med. 2001;67:811–814. [PubMed
      15. Zhang CR, Yang SP, Yue JM. Sterols and triterpenoids from the spores of Ganoderma Lucidum. Nat Prod Res. 2008;22(13):1137–1142. [PubMed
      16. Zhang XQ, Pang GL, Cheng Y, et al. Chemical constituents of the spores of Ganoderma Lucidum. J Chin Med Mat. 2008;31(1):41–44. [PubMed
      17. Liu GT, Bao X, Niu S, et al. Some pharmacological actions of the spores of Ganoderma lucidum and the mycelium of Ganoderma capense (Lloyd) Teng cultivated by submerged fermentation. Chin Med J. 1979;92:469–500. [PubMed
      18. Liu QY, Sartippour MR, Brooks MN, et al. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol Rep. 2004;12:659–662. [PubMed
      19. Zhu HS, Yang XL, Wang LB, et al. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on Hela cells. Cell Bio Toxicol. 2006;16:201–206. [PubMed
      20. Ma L, Wu F, Chen RY. Analysis of triterpene constituents from Ganoderma lucidum. Acta Pharm Sin. 2003;38:50–52. 
      21. Sliva D, Sedlak M, Slivova V, et al. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Comple Med. 2003;9:491–497. [PubMed

       

      .........................